Report Scope:
This report addresses the global market for microbes and microbial products used in commercial applications from 2021 through 2027. This includes agricultural, healthcare, manufacturing, energy, and environmental applications.

Viruses are sometimes classified as microbes, but they are nonliving, and thus they are excluded from this report.

Major elements cited in this study include -

  • Summary.
  • Definitions.
  • Description of microbes.
  • Microbe end-uses and applications.
  • Regulation.
  • Recent technological developments.
  • Market size and segmentation from 2021 to 2027.
  • Company profiles.
  • Key patents.

Report Includes:

  • 27 tables
  • An overview of the global market and technologies for microbial products with special focus on their applications
  • Estimation of the market size and analyses of global market trends, with data from 2019-2021, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential and quantification of microbial products market based on type, application, and region
  • Detailed descriptions of probiotics, their types, and recent developments and information on microbial pesticides and biofertilizers and their potential uses
  • Analysis of underlying technological, environmental, legal/regulatory, and political trends that may influence the size and nature of the market
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
  • Comprehensive company profiles of the leading players of the industry, including Seres Therapeutics, Enterome Biosciences, Ferring Pharmaceutics, Evelo Biosciences, Finch Therapeutics, Microbiome Therapeutics, and Pylum Biosciences